Arcis Biotechnology Limited

10 articles about Arcis Biotechnology Limited

• 

  BioSpace Movers and Shakers, July 26

  7/26/2019

  Biotech and pharma companies bolster their executive leadership and boards of directors with this week's appointments.

• Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

  7/24/2019

  Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.

• 

  BioSpace Global Roundup, July 18

  7/18/2019

  Pharma and biotech companies from across the globe provide updates on their pipelines and corporate strategy.

• Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology

  7/16/2019

  Enables stabilisation of microRNA biomarkers for early disease diagnosis

• Arcis Biotechnology and Opentrons Sign Distribution Agreement

  7/9/2019

  Providing researchers with an automated solution for two-step nucleic acid sample preparation

• Andrew Alliance Announces Co-marketing Agreement With Arcis Biotechnology to Offer Hands-free Nucleic Acid Stabilization and Preparation

  5/14/2019

  Andrew Alliance and Arcis Biotechnology today announced a co-marketing relationship for deploying protocols that automate sample preparation for nucleic acid analysis on Andrew Alliance platforms.

• Arcis Biotechnology and Teleflex Sign License Agreement

  10/16/2018

  Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology

• Arcis Biotechnology Raises £1.25 Million (USD $1.63 Million) Funding and Opens Further £0.5 Million Investment Opportunity Through Capital Cell

  10/2/2018

  £1.25 million already secured based on pre-money valuation of £18.2 million

• Arcis Biotechnology Awarded Funding Under Innovate UK’s Biocatalyst Programme

  1/31/2017

• Arcis Biotechnology Launches IVD For The Preparation Of DNA From Blood

  10/11/2016